{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:16:30Z","timestamp":1789848990595,"version":"4.0.1"},"reference-count":46,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4,10]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>NR4A1 is downregulated in aggressive B-cell lymphoma. Its overexpression causes apoptosis in lymphoma cells and suppresses lymphoma formation in vivo.<\/jats:p>","DOI":"10.1182\/blood-2013-08-518878","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T06:31:10Z","timestamp":1392877870000},"page":"2367-2377","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":42,"title":["NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas"],"prefix":"10.1182","volume":"123","author":[{"given":"Alexander J. A.","family":"Deutsch","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Center for Medical Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Rinner","sequence":"additional","affiliation":[{"name":"Center for Medical Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wenzl","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Center for Medical Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pichler","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Troppan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Center for Medical Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Steinbauer","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Medical University Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schwarzenbacher","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Reitter","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Feichtinger","sequence":"additional","affiliation":[{"name":"Institute for Genomics and Bioinformatics\/Institute of Biochemistry, Graz University of Technology, Austria;"},{"name":"Austrian Centre of Industrial Biotechnology, Graz, Austria;"},{"name":"Omics Center Graz, Austria, RNA Biology Group, Institute of Molecular Biotechnology, Graz University of Technology, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Tierling","sequence":"additional","affiliation":[{"name":"Department of Genetics\/Epigenetics, FR8.3 Life Sciences, Saarland University, Saarbr\u00fccken, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Prokesch","sequence":"additional","affiliation":[{"name":"Institute for Genomics and Bioinformatics\/Institute of Biochemistry, Graz University of Technology, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Scheideler","sequence":"additional","affiliation":[{"name":"Omics Center Graz, Austria, RNA Biology Group, Institute of Molecular Biotechnology, Graz University of Technology, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Krogsdam","sequence":"additional","affiliation":[{"name":"Division of Bioinformatics, Biocenter Innsbruck, Innsbruck Medical University, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard G.","family":"Thallinger","sequence":"additional","affiliation":[{"name":"Institute for Genomics and Bioinformatics\/Institute of Biochemistry, Graz University of Technology, Austria;"},{"name":"Austrian Centre of Industrial Biotechnology, Graz, Austria;"},{"name":"Omics Center Graz, Austria, RNA Biology Group, Institute of Molecular Biotechnology, Graz University of Technology, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Schaider","sequence":"additional","affiliation":[{"name":"Dermatology Research Centre, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Beham-Schmid","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Medical University Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Neumeister","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Center for Medical Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2019111817134190100_B1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project.","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111817134190100_B2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.2807","article-title":"The molecular background of aggressive B cell lymphomas as a basis for targeted therapy.","volume":"223","author":"de Jong","year":"2011","journal-title":"J Pathol"},{"issue":"15","key":"2019111817134190100_B3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas.","volume":"362","author":"Lenz","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111817134190100_B4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.","volume":"29","author":"Meyer","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111817134190100_B5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2174\/187152012803529619","article-title":"The nuclear orphan receptors NR4A as therapeutic target in cancer therapy.","volume":"12","author":"Deutsch","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"issue":"6","key":"2019111817134190100_B6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/14728222.2012.680958","article-title":"Nur77: a potential therapeutic target in cancer.","volume":"16","author":"To","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"2019111817134190100_B7","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1078-0432.CCR-11-2953","article-title":"Molecular pathways: the role of NR4A orphan nuclear receptors in cancer.","volume":"18","author":"Mohan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019111817134190100_B8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm1579","article-title":"Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.","volume":"13","author":"Mullican","year":"2007","journal-title":"Nat Med"},{"issue":"9","key":"2019111817134190100_B9","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood-2010-02-267906","article-title":"Reduced NR4A gene dosage leads to mixed myelodysplastic\/myeloproliferative neoplasms in mice.","volume":"117","author":"Ramirez-Herrick","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111817134190100_B10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nchembio.106","article-title":"Cytosporone B is an agonist for nuclear orphan receptor Nur77.","volume":"4","author":"Zhan","year":"2008","journal-title":"Nat Chem Biol"},{"key":"2019111817134190100_B11","volume-title":"World Health Organisation classification of tumors: Pathology and genetics of tumors of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"issue":"1","key":"2019111817134190100_B12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2019111817134190100_B13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2011.03.014","article-title":"Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells.","volume":"308","author":"Wohlkoenig","year":"2011","journal-title":"Cancer Lett"},{"issue":"4","key":"2019111817134190100_B14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.leu.2402880","article-title":"Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.","volume":"17","author":"Lossos","year":"2003","journal-title":"Leukemia"},{"issue":"24","key":"2019111817134190100_B15","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1093\/emboj\/cdg620","article-title":"Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor.","volume":"22","author":"Rajpal","year":"2003","journal-title":"EMBO J"},{"key":"2019111817134190100_B16","first-page":"74","article-title":"Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases.","volume":"9","author":"Hughes","year":"2006","journal-title":"Curr Dir Autoimmun"},{"issue":"8","key":"2019111817134190100_B17","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/sj.cdd.4401940","article-title":"BH3-only proteins in cell death initiation, malignant disease and anticancer therapy.","volume":"13","author":"Labi","year":"2006","journal-title":"Cell Death Differ"},{"issue":"6513","key":"2019111817134190100_B18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/373444a0","article-title":"Fas(CD95)\/FasL interactions required for programmed cell death after T-cell activation.","volume":"373","author":"Ju","year":"1995","journal-title":"Nature"},{"issue":"5309","key":"2019111817134190100_B19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL.","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"issue":"17","key":"2019111817134190100_B20","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","article-title":"TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.","volume":"16","author":"Walczak","year":"1997","journal-title":"EMBO J"},{"issue":"22","key":"2019111817134190100_B21","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111817134190100_B22","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2010-05-285403","article-title":"Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.","volume":"116","author":"Jima","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111817134190100_B23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4161\/epi.25242","article-title":"Bi-PROF: bisulfite profiling of target regions using 454 GS FLX Titanium technology.","volume":"8","author":"Gries","year":"2013","journal-title":"Epigenetics"},{"issue":"2","key":"2019111817134190100_B24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research.","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2019111817134190100_B25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3109\/10428191003728628","article-title":"Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.","volume":"51","author":"Alizadeh","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2019111817134190100_B26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1532","article-title":"Reverse engineering of regulatory networks in human B cells.","volume":"37","author":"Basso","year":"2005","journal-title":"Nat Genet"},{"issue":"10","key":"2019111817134190100_B27","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.","volume":"205","author":"Brune","year":"2008","journal-title":"J Exp Med"},{"issue":"7247","key":"2019111817134190100_B28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"11","key":"2019111817134190100_B29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med"},{"issue":"25","key":"2019111817134190100_B30","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"2019111817134190100_B31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2172-5-20","article-title":"Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs.","volume":"5","author":"Shen","year":"2004","journal-title":"BMC Immunol"},{"issue":"17","key":"2019111817134190100_B32","first-page":"5401","article-title":"TR3\/Nur77 in colon cancer cell apoptosis.","volume":"63","author":"Wilson","year":"2003","journal-title":"Cancer Res"},{"issue":"26","key":"2019111817134190100_B33","doi-asserted-by":"crossref","first-page":"24903","DOI":"10.1074\/jbc.M500107200","article-title":"Activation of Nur77 by selected 1,1-Bis(3\u2032-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways.","volume":"280","author":"Chintharlapalli","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"2019111817134190100_B34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","article-title":"Ecological and evolutionary forces shaping microbial diversity in the human intestine.","volume":"124","author":"Ley","year":"2006","journal-title":"Cell"},{"issue":"18","key":"2019111817134190100_B35","doi-asserted-by":"crossref","first-page":"11878","DOI":"10.1073\/pnas.182552499","article-title":"Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2019111817134190100_B36","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1002\/eji.1830250915","article-title":"Involvement of NAK-1, the human nur77 homologue, in surface IgM-mediated apoptosis in Burkitt lymphoma cell line BL41.","volume":"25","author":"Mapara","year":"1995","journal-title":"Eur J Immunol"},{"issue":"1","key":"2019111817134190100_B37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-005-9026-6","article-title":"cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.","volume":"96","author":"Villeneuve","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2019111817134190100_B38","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma.","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111817134190100_B39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2019111817134190100_B40","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2019111817134190100_B41","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma.","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"5440","key":"2019111817134190100_B42","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.286.5440.790","article-title":"Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2.","volume":"286","author":"Youn","year":"1999","journal-title":"Science"},{"issue":"4","key":"2019111817134190100_B43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0092-8674(04)00162-X","article-title":"Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77\/TR3.","volume":"116","author":"Lin","year":"2004","journal-title":"Cell"},{"issue":"8","key":"2019111817134190100_B44","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/MCB.18.8.4719","article-title":"Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines.","volume":"18","author":"Li","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2019111817134190100_B45","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1038\/oncsis.2012.19","article-title":"Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia.","volume":"1","author":"Boudreaux","year":"2012","journal-title":"Oncogenesis"},{"issue":"8","key":"2019111817134190100_B46","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/emboj\/16.8.1865","article-title":"Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis.","volume":"16","author":"Cheng","year":"1997","journal-title":"EMBO J"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/15\/2367\/1375306\/2367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/15\/2367\/1375306\/2367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T22:14:07Z","timestamp":1574115247000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/15\/2367\/32252\/NR4A1mediated-apoptosis-suppresses-lymphomagenesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,10]]},"references-count":46,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,4,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2013-08-518878","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,10]]}}}